Glaxo CEO on U.K. China Trade Mission Amid Bribery Probe

GlaxoSmithKline Plc Chief Executive Officer Andrew Witty joined U.K. Prime Minister David Cameron on a trade mission to China today as his company faces a corruption investigation in the country.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.